Enzo Biochem, Inc.
ENZ
Market Cap$16.44M
Close$
$-1.14
462.5% downside
Current Fair Value
462.5% downsideOvervalued by 462.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $16.44 Million |
|---|---|
| Enterprise Value | $-20,934,001.00 |
| Dividend Yield | $0.4 (20.4081632653061%) |
| Earnings per Share | $-0.51 |
| Beta | 1.16 |
| Outstanding Shares | 52,297,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -1.2 |
|---|---|
| PEG | 2.46 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | -0.69 |
| Enterprise Value to EBIT | 2.5 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -0.14 |
| Debt to Equity | 0.06 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Enzo Biochem, Inc.
CEO: Elazar Rabbani